|
|
Sold Out
Book Categories |
| NMR Spectroscopy of Platinum Drugs: From DNA to Body Fluids | 1 | |
| Trans-Diamminedichloroplatinum (II) Is Not an Antitumor Drug: Why? | 17 | |
| Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumor Activity | 27 | |
| Molecular Dynamics Simulations on Cisplatin Adducts with Dinucleotides | 37 | |
| Orally Active DACH-Pt (IV) Compounds | 43 | |
| Pharmacokinetic - Pharmacodynamic Relationships | 53 | |
| Clinical Pharmacology of Carboplatin Administered in Alternating Sequence with Paclitaxel in Patients with Non-Small Cell Lung Cancer: A European Cancer Centre (ECC) Study | ||
| The Clinical Development of the Oral Platinum Anticancer Agent JM216 | 83 | |
| Membrane Transport of Platinum Compounds | 91 | |
| Detection of Adducts Formed upon Treatment of DNA with Cisplatin and Carboplatin | 107 | |
| Detection of Platinum Lesions at the Nucleotide Level in Cells using Single Strand Ligation PCR | 121 | |
| A Review of the Modulation of Cisplatin Toxicities by Chemoprotectants | 131 | |
| Combination Therapy with Cisplatinum and EGF Receptor Blockade | 155 | |
| Oxaliplatin: Update on an Active and Safe Dach Platinum Complex | 165 | |
| Combination of Different Platinum Compounds: Issues, Strategies and Experience | 175 | |
| Phase I and II Studies with Lobaplatin | 181 | |
| Phase I Trials of Ormaplatin (NSC 363812) | 187 | |
| 254-S, NK121 and TRK710 | 193 | |
| Clinical Trials of Oxaliplatin and DWA2114R | 199 | |
| Incorporating Assessments of Sequence-Dependence in Developmental Studies of Combination Chemotherapy Regimens Containing New Agents and Platinum Compounds | 205 | |
| Review of Carboplatin-Based High-Dose Chemotherapy Combinations in the Autotransplant Setting | 221 | |
| Treatment Intensification in Germ-Cell Tumours | 229 | |
| IL-I[alpha] Enhancement of Platinum-Mediated Anti-Tumor Activity | ||
| Overview of Tumor-Inhibiting Non-Platinum Complexes | 253 | |
| The Cisplatin-Induced Cellular Injury Response | 269 | |
| The Interaction of Cisplatin with Signal Transduction Pathways and the Regulation of Apoptosis | 283 | |
| Cell Cycle Checkpoints and Cancer Chemotherapy | 293 | |
| Carboplatin versus Cisplatin in the Chemotherapy of Solid Tumors: Pro-Carboplatin | 303 | |
| Cisplatin and Carboplatin in Testis and Ovarian Cancer: Pro Cisplatin | 311 | |
| Hypersensitivity to Cisplatin in Mouse Leukemia L1210/0 Cells: An XPG DNA Repair Defect | 317 | |
| DNA Repair and the Carrier Ligand Specificity of Platinum Resistance | 327 | |
| Transcription Factor Differences in Cisplatin Resistant Cells | 341 | |
| Index | 347 |
| Price | Condition | Delivery | Seller | Action |
| $219.84 | Digital |
| WonderClub |
Curtis Haley
reviewed Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2, Vol. 2 on March 02, 2014
Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2
A nice little intro to a fascinating but overlooked subject. The only improvement to it would be the inclusion of color photographs and perhaps distribution maps.
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish List
X
This item is in your Collection
Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2, Vol. 2
X
This Item is in Your Inventory
Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2, Vol. 2
X
You must be logged in to review the productsX
X
X
Add Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2, Vol. 2, , Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2, Vol. 2 to the inventory that you are selling on WonderClubX
X
Add Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2, Vol. 2, , Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2, Vol. 2 to your collection on WonderClub |
